Sep 22, 2025 07:30AM
Dec 3, 2024 07:30AM
Aug 8, 2024 05:06PM
May 14, 2024 04:01PM
Aug 10, 2023 04:02PM
Jun 10, 2023 12:00PM
May 8, 2023 04:01PM Aptose Reports Results for the First Quarter 2023
Mar 23, 2023 04:44PM
Jan 30, 2023 07:00AM
Nov 1, 2022 04:01PM
Sep 12, 2022 07:30AM
May 9, 2022 04:01PM
May 4, 2022 07:30AM
May 4, 2021 04:01PM Aptose Reports Results for the First Quarter 2021
Mar 23, 2021 04:01PM
Mar 16, 2021 07:30AM
Aug 4, 2020 04:01PM
Jun 29, 2020 07:06AM
Jun 29, 2020 07:01AM
May 5, 2020 04:00PM
Mar 10, 2020 04:02PM Aptose Reports Results for the Fourth Quarter and Full Year 2019
Nov 5, 2019 04:02PM
Aug 6, 2019 04:00PM
Jul 16, 2019 07:05AM
May 7, 2019 04:01PM
Apr 1, 2019 01:00PM
Mar 25, 2019 07:02AM
Mar 12, 2019 04:02PM Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2018
Feb 25, 2019 07:00AM
Nov 6, 2018 04:05PM
Aug 7, 2018 04:18PM
Jun 29, 2018 07:00AM
Jun 4, 2018 07:04AM
May 10, 2018 04:00PM
Apr 17, 2018 02:00PM Aptose Presents Preclinical Data on APTO-253 at 2018 AACR Annual Meeting
Mar 28, 2018 08:00AM
Mar 27, 2018 04:15PM
Feb 7, 2018 04:01PM
Dec 26, 2017 07:30AM
Dec 26, 2017 07:30AM
Nov 14, 2017 04:00PM
Oct 30, 2017 08:10AM Aptose Biosciences (APTO) Reports $15.5M Common Shares Purchase Agreement with Aspire Capital Fund
Oct 30, 2017 08:00AM
Aug 8, 2017 04:05PM
Mar 28, 2017 05:03PM
Dec 29, 2016 08:01AM
Dec 29, 2016 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All